Hypertriglyceridemia in an outpatient department - Significance as an atherosclerotic risk factor

被引:1
作者
Scholz, M. [1 ]
Tselmin, S. [1 ]
Fischer, S. [1 ]
Julius, U. [1 ]
机构
[1] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Internal Med 3, D-01307 Dresden, Germany
关键词
Hypertriglyceridemia; Cardiovascular risk; Pancreatitis; Atherosclerosis; Triglycerides; CORONARY-HEART-DISEASE; LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR-DISEASE; FATTY-ACIDS; TRIGLYCERIDES; MECHANISM; THERAPY; PANCREATITIS; STATINS; PROTEIN;
D O I
10.1016/j.atherosclerosissup.2015.02.011
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Although a relationship between elevated triglycerides (TG) and cardiovascular diseases is generally accepted, its extent is still discussed. This retrospective study analyzed the incidence of cardiovascular events (CVE) and pancreatitis as well as the therapeutic regimen in patients being treated for hypertriglyceridemia (HTG) at an outpatient department. Methods: The cohort included 183 patients with mild and 49 patients with severe HTG; subgroups were formed and compared according to gender, presence of metabolic vascular syndrome (MVS) and lipid values. Results: Patients in this study seem to have had CVE at younger age than reported event rates in the general population. TG levels, rates of CVE and pancreatitis were reduced in all groups during therapy, which could be linked to use of omega-3 fatty acids and fibrates. Patients with persisting severe HTG as a result of incompliance showed massive risk for pancreatitis. Conclusion: Although no significant association between TG levels and CVE could be established, the combination of HTG and other cardiovascular risk factors such as MVS seems to be especially dangerous. The lipid-lowering drug therapy appeared to be effective with respect to CVE and pancreatitis incidence. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:146 / 153
页数:8
相关论文
共 48 条
[1]   Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance [J].
Adiels, M. ;
Westerbacka, J. ;
Soro-Paavonen, A. ;
Haekkinen, A. M. ;
Vehkavaara, S. ;
Caslake, M. J. ;
Packard, C. ;
Olofsson, S. O. ;
Yki-Jaervinen, H. ;
Taskinen, M. R. ;
Boren, J. .
DIABETOLOGIA, 2007, 50 (11) :2356-2365
[2]  
[Anonymous], 2013, PRACTICAL GUIDELINE
[3]  
Assmann G, 1998, EUR HEART J, V19, pA2
[4]   Hypertriglyceridemia as a cardiovascular risk factor [J].
Austin, MA ;
Hokanson, JE ;
Edwards, KL .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (4A) :7B-12B
[5]   Hypertriglyceridemia causes more severe course of acute pancreatitis [J].
Baranyai, Tamas ;
Terzin, Viktoria ;
Vajda, Agota ;
Wittmann, Tibor ;
Czako, Laszlo .
CLINICAL LIPIDOLOGY, 2012, 7 (06) :731-736
[6]   Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy [J].
Boden, William E. ;
Probstfield, Jeffrey L. ;
Anderson, Todd ;
Chaitman, Bernard R. ;
Desvignes-Nickens, Patrice ;
Koprowicz, Kent ;
McBride, Ruth ;
Teo, Koon ;
Weintraub, William .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (24) :2255-2267
[7]   Postprandial hypertriglyceridemia as a coronary risk factor [J].
Boren, Jan ;
Matikainen, Niina ;
Adiels, Martin ;
Taskinen, Marja-Riitta .
CLINICA CHIMICA ACTA, 2014, 431 :131-142
[8]   n-3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia [J].
Bosch, Jackie ;
Gerstein, Hertzel C. ;
Dagenais, Gilles R. ;
Diaz, Rafael ;
Dyal, Leanne ;
Jung, Hyejung ;
Maggiono, Aldo P. ;
Probstfield, Jeffrey ;
Ramachandran, Ambady ;
Riddle, Matthew C. ;
Ryden, Lars E. ;
Yusuf, Salim .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (04) :309-318
[9]   Serum triglycerides and risk of cardiovascular disease [J].
Boullart, A. C. I. ;
de Graaf, J. ;
Stalenhoef, A. F. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2012, 1821 (05) :867-875
[10]  
Brunzell JD., METABOLIC MOL BASE I